Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Japan
  4. Japan Exchange
  5. Daiichi Sankyo Company, Limited
  6. Onderneming
    4568   JP3475350009

DAIICHI SANKYO COMPANY, LIMITED

(4568)
OverzichtGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningen 
Beroep
Daiichi Sankyo Company is gespecialiseerd in de ontwikkeling, productie en marketing van farmaceutische producten. De netto-omzet is als volgt verdeeld naar activiteit:

- verkoop van geneesmiddelen (99,8%): geneesmiddelen op recept (92,8% van de netto-omzet) en OTC-geneesmiddelen (7,2%) voornamelijk voor de behandeling van trombotische aandoeningen, tumoren, diabetes en reumatoÔde artritis;

- overige (0,2%): voornamelijk vastgoedactiviteiten.

De netto-omzet is geografisch als volgt verdeeld: Japan (64,1%), Noord-Amerika (17,2%), Europa (9,7%) en overige (9%).

Aantal werknemers : 16 033 mensen.
Verkoop per activiteit
20202021Delta
Prescription Drugs911 262.0092.8%892 923.0092.8% -2.01%
Health Care68 403.007%67 425.007% -1.43%
Other2 127.000.2%2 167.000.2% +1.88%
JPY in miljoenen
Verkoop per regio
20202021Delta
Japan607 712.0061.9%560 725.0058.3% -7.73%
North America183 081.0018.6%191 651.0019.9% +4.68%
Europe95 728.009.8%114 047.0011.8% +19.14%
Other95 271.009.7%96 091.0010% +0.86%
JPY in miljoenen
Managers
Naam Titel Leeftijd Van
Sunao Manabe President, CEO & Representative Director 67 2019
Hiroyuki Okuzawa CFO, Director, Executive Officer & Head-Management 58 2021
Ken Takeshita Global Director-Research & Development - 2021
Noritaka Uji Independent Outside Director 72 2014
Tsuguya Fukui Independent Outside Director 70 2015
Kazuaki Kama Independent Outside Director 72 2019
Sawako Nohara Independent Outside Director 63 2019
Ryoji Nagasaka Managing Executive Officer & Head-Secretariat - 2016
Junichi Koga Senior Managing Executive Officer, Global Head-R&D - 2019
Satoru Kimura Representative Director & Senior Executive Officer 63 2021
Bestuurders
Naam Titel Leeftijd Van
Sunao Manabe President, CEO & Representative Director 67 2019
Noritaka Uji Independent Outside Director 72 2014
Satoru Kimura Representative Director & Senior Executive Officer 63 2021
Masahiko Ohtsuki Director & Senior Executive Officer - 2020
Tsuguya Fukui Independent Outside Director 70 2015
Kazuaki Kama Independent Outside Director 72 2019
Sawako Nohara Independent Outside Director 63 2019
Shoji Hirashima Director & Senior Executive Officer - 2020
Hiroyuki Okuzawa CFO, Director, Executive Officer & Head-Management 58 2021
Aandelen
Stemming AantalPercentage vrij verhandelbaarBedrijfseigen aandelenDrijvend Totaal
Aandeel A 0.01 1 947 034 029 1 899 748 309 97.6% 30 606 239 1.6% 97.6%
Aandeelhouders
NaamAandelen%
Capital Research & Management Co. (World Investors) 122 207 450 6,28%
Nippon Life Insurance Co. 107 328 000 5,51%
Nomura Asset Management Co., Ltd. 101 045 800 5,19%
Sumitomo Mitsui Trust Asset Management Co., Ltd. 68 223 600 3,50%
Capital Research & Management Co. (Global Investors) 55 040 900 2,83%
The Vanguard Group, Inc. 47 194 766 2,42%
Mizuho Bank Pension Fund 43 208 000 2,22%
Nikko Asset Management Co., Ltd. 41 392 500 2,13%
Daiwa Asset Management Co. Ltd. 40 112 287 2,06%
Wellington Management Co. LLP 36 707 656 1,89%
Belangnemingen
NaamAandelen%Totale waarde
THE SHIZUOKA BANK, LTD. (8355) 9 343 000 1,57% 73 308 448 USD
ALFRESA HOLDINGS CORPORATION (2784) 3 202 144 1,36% 50 745 785 USD
COCOKARA FINE INC. (3098) 605 000 1,93% 47 690 698 USD
MEDIPAL HOLDINGS CORPORATION (7459) 2 184 007 0,89% 41 807 463 USD
SUZUKEN CO., LTD. (9987) 952 598 0,92% 28 354 232 USD
TORAY INDUSTRIES, INC. (3402) 3 339 000 0,20% 22 545 696 USD
AIN HOLDINGS INC. (9627) 114 000 0,32% 7 709 994 USD
HOKUYAKU TAKEYAMA HOLDINGS,INC. (3055) 438 500 1,80% 2 873 841 USD
THE IYO BANK, LTD. (8385) 470 000 0,15% 2 519 844 USD
SUMITOMO MITSUI TRUST HOLDINGS, INC. (8309) 22 485 0,0060% 736 401 USD
Markten en indices
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50, Stoxx Global 200
Beurscodes
- Bloomberg-code :  4568:JP
- Reuters Code :  4568.T
- Datastreamcode :  
Bedrijfsgegevens
Daiichi Sankyo Co., Ltd.
Daiichi Sankyo Building A/B 3-5-1 Nihonbashi-Honcho
JP-103-8426 Chuo-ku, Tokyo

Telefoon : +81 3 6225 1111
Fax :
Internet : https://www.daiichisankyo.com/
Merk portefeuille
In samenwerking metMijn merken op de beurs
Meer merken vanDaiichi Sankyo Company, Limited
Sector Farmaceutische producten - Andere
Verschil t.o.v. 1 jan (%)Kapitalisatie (M$)
DAIICHI SANKYO COMPANY, LIMITED-14.46%53 264
JOHNSON & JOHNSON3.68%429 542
ROCHE HOLDING AG9.24%319 352
PFIZER, INC.19.37%244 283
NOVO NORDISK A/S48.08%227 557
ELI LILLY AND COMPANY34.09%205 250
ABBVIE INC.0.53%190 360
MERCK & CO., INC.-10.32%185 702
NOVARTIS AG-8.36%185 289
ASTRAZENECA PLC16.97%181 937
BRISTOL-MYERS SQUIBB COMPANY-3.53%132 971
AMGEN INC.-7.31%121 015
SANOFI4.35%120 616
GLAXOSMITHKLINE PLC3.37%95 179
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-23.81%62 650
BAYER AG-1.79%54 369
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.00%53 442
JIANGSU HENGRUI MEDICINE CO., LTD.-45.75%50 085
ASTELLAS PHARMA INC.17.60%31 313
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY50.32%24 839